Brief: Akoya Biosciences Q4 revenue USD 21.2 million
06/03/2023 21:10
Mar 6 (Reuters) - Akoya Biosciences Q4 EPS USD -0.5. * Outlook FY revenue USD 95-98 million * Q4 revenue USD 21.2 million * Q4 gross margin 57% * Q4 gross profit USD 12 million
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks